Home > Insider Trading > Filing (0001209191-18-057771)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
914475	Neurocrine Biosciences Inc	NBIX	Biological Products, (No Disgnostic Substances) (2836)	330525145

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557146	Malcolm Lloyd-Smith	12780 El Camino Real San Diego CA 92130	Chief Regulatory Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-11-06	5,700	$15.45	21,018	No	4	M	Direct
Common Stock	Disposition	2018-11-06	5,700	$110.02	15,318	No	4	S	Direct
Common Stock	Acquisiton	2018-11-07	3,300	$15.45	18,618	No	4	M	Direct
Common Stock	Disposition	2018-11-07	3,300	$110.00	15,318	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Acquisiton	2018-11-06	5,700	$15.45	5,700	$15.45
Common Stock	Non-Qualified Stock Option	Acquisiton	2018-11-07	3,300	$15.45	3,300	$15.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,256		2024-10-01	No	4	M	Direct
9,956		2024-10-01	No	4	M	Direct

Footnotes

The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Option granted October 1, 2014 and vested 25% upon first anniversary (October 1, 2015) and remaining 75% vested in 36 equal monthly installments beginning November 1, 2015.